Literature DB >> 21874012

Histopathological and immunohistochemical findings of 20 autopsy cases with 2009 H1N1 virus infection.

Noriko Nakajima1, Yuko Sato, Harutaka Katano, Hideki Hasegawa, Toshio Kumasaka, Satoru Hata, Shinya Tanaka, Tomonori Amano, Takahiko Kasai, Ja-Mun Chong, Toshihiko Iizuka, Toshihiko Iiduka, Iwao Nakazato, Yohko Hino, Akihiko Hamamatsu, Hisashi Horiguchi, Tomoyuki Tanaka, Akio Hasegawa, Akio Hasagawa, Yoshiaki Kanaya, Reiko Oku, Takeshi Oya, Tetsutaro Sata.   

Abstract

Twenty autopsy cases with 2009 pandemic influenza A (2009 H1N1) virus infection, performed between August 2009 and February 2010, were histopathologically analyzed. Hematoxylin-eosin staining, immunohistochemistry for type A influenza nucleoprotein antigen, and real-time reverse transcription-PCR assay for viral RNA were performed on formalin-fixed and paraffin-embedded specimens. In addition, the D222G amino acid substitution in influenza virus hemagglutinin, which binds to specific cell receptors, was analyzed in formalin-fixed and paraffin-embedded trachea and lung sections by direct sequencing of PCR-amplified products. There were several histopathological patterns in the lung according to the most remarkable findings in each case: acute diffuse alveolar damage (DAD) with a hyaline membrane (four cases), organized DAD (one case), acute massive intra-alveolar edema with variable degrees of hemorrhage (three cases), neutrophilic bronchopneumonia (five cases) and tracheobronchitis with limited histopathological changes in alveoli (four cases). In two cases, the main findings were due to preexisting disease. Influenza virus antigen was only detected in the respiratory tract in 10 cases by immunohistochemistry. The antigen was detected in type II pneumocytes (three cases) in the epithelial cells of the trachea, bronchi and glands (six cases), and in the epithelial cells in both of the above (one case). The four cases with acute DAD presented with antigen-positive type II pneumocytes. In one case, the D222G substitution was detected in the lung as a major sequence, although 222D was prominent in the trachea, suggesting that selection of the viral clones occurred in the respiratory tract. In five cases, the pathogenesis of 2009 H1N1 was confirmed to be viral infection in pneumocytes, which caused severe alveolar damage and fatal viral pneumonia. Further studies on both host and viral factors in autopsy or biopsy materials will be essential to elucidate the other pathogenic factors involved in influenza virus infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21874012     DOI: 10.1038/modpathol.2011.125

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  37 in total

1.  A Three-Dimensional Human Tissue-Engineered Lung Model to Study Influenza A Infection.

Authors:  Rudra Bhowmick; Tahereh Derakhshan; Yurong Liang; Jerry Ritchey; Lin Liu; Heather Gappa-Fahlenkamp
Journal:  Tissue Eng Part A       Date:  2018-06-29       Impact factor: 3.845

2.  Differential pathological and immune responses in newly weaned ferrets are associated with a mild clinical outcome of pandemic 2009 H1N1 infection.

Authors:  Stephen S H Huang; David Banner; Norbert Degousee; Alberto J Leon; Louling Xu; Stephane G Paquette; Thirumagal Kanagasabai; Yuan Fang; Salvatore Rubino; Barry Rubin; David J Kelvin; Alyson A Kelvin
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

3.  Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection.

Authors:  Pooja A Kumar; Yuanyu Hu; Yusuke Yamamoto; Neo Boon Hoe; Tay Seok Wei; Dakai Mu; Yan Sun; Lim Siew Joo; Rania Dagher; Elisabeth M Zielonka; De Yun Wang; Bing Lim; Vincent T Chow; Christopher P Crum; Wa Xian; Frank McKeon
Journal:  Cell       Date:  2011-10-28       Impact factor: 41.582

4.  IL-22 is essential for lung epithelial repair following influenza infection.

Authors:  Derek A Pociask; Erich V Scheller; Sivanarayana Mandalapu; Kevin J McHugh; Richard I Enelow; Cheryl L Fattman; Jay K Kolls; John F Alcorn
Journal:  Am J Pathol       Date:  2013-03-11       Impact factor: 4.307

5.  Emergence of HA mutants during influenza virus pneumonia.

Authors:  Maria Eugenia Vázquez Manríquez; Akiko Makino; Motoko Tanaka; Yasuhisa Abe; Hiroyuki Yoshida; Ichiro Morioka; Soichi Arakawa; Yasuhiro Takeshima; Kentaro Iwata; Jin Takasaki; Toshie Manabe; Takaaki Nakaya; Shota Nakamura; Anjarath Lorena Higuera Iglesias; Rosa Maria Rivera Rossales; Erika Pena Mirabal; Tateki Ito; Toshio Kitazawa; Teruaki Oka; Makoto Yamashita; Koichiro Kudo; Kyoko Shinya
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

6.  Peptide targeting and imaging of damaged lung tissue in influenza-infected mice.

Authors:  Na Li; Lu Yin; Damien Thévenin; Yoshiyuki Yamada; Gino Limmon; Jianzhu Chen; Vincent Tk Chow; Donald M Engelman; Bevin P Engelward
Journal:  Future Microbiol       Date:  2013-02       Impact factor: 3.165

7.  Tissue factor deficiency increases alveolar hemorrhage and death in influenza A virus-infected mice.

Authors:  S Antoniak; K Tatsumi; Y Hisada; J J Milner; S D Neidich; C M Shaver; R Pawlinski; M A Beck; J A Bastarache; N Mackman
Journal:  J Thromb Haemost       Date:  2016-04-05       Impact factor: 5.824

8.  Computational pathology reveals unique spatial patterns of immune response in H&E images from COVID-19 autopsies: preliminary findings.

Authors:  Germán Corredor; Paula Toro; Kaustav Bera; Dylan Rasmussen; Vidya Sankar Viswanathan; Christina Buzzy; Pingfu Fu; Lisa M Barton; Edana Stroberg; Eric Duval; Hannah Gilmore; Sanjay Mukhopadhyay; Anant Madabhushi
Journal:  J Med Imaging (Bellingham)       Date:  2021-07-13

Review 9.  COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion.

Authors:  Frank L van de Veerdonk; Roger J M Brüggemann; Shoko Vos; Gert De Hertogh; Joost Wauters; Monique H E Reijers; Mihai G Netea; Jeroen A Schouten; Paul E Verweij
Journal:  Lancet Respir Med       Date:  2021-05-26       Impact factor: 30.700

10.  Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus.

Authors:  Masaya Fukushi; Makoto Yamashita; Tohru Miyoshi-Akiyama; Shuku Kubo; Kenji Yamamoto; Koichiro Kudo
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.